Recent Publications
Circulating Tumor DNA as a Novel Prognostic Biomarker of Therapeutic Efficacy in Patients with Unresectable Colorectal Liver Metastases Treated with Hepatic Arterial Infusion.
Journal Article Ann Surg Oncol · October 2025 BACKGROUND: Hepatic arterial infusion (HAI) chemotherapy is an expanding treatment for patients with unresectable colorectal liver metastases (uCRLM). This study examined circulating tumor DNA (ctDNA) as a novel biomarker to prognosticate oncologic outcome ... Full text Link to item CiteASO Author Reflections: Towards Personalized Cancer Therapy: The Role of ctDNA as a Biomarker in Patients with Unresectable Colorectal Liver Metastases Treated with Hepatic Arterial Infusion.
Journal Article Ann Surg Oncol · October 2025 Full text Link to item CiteRobotic Versus Open Placement of Hepatic Artery Infusion Pumps.
Journal Article Ann Surg Oncol · May 2025 BACKGROUND: A growing number of centers offer hepatic artery infusion pump (HAIP) chemotherapy for advanced liver malignancies. While small series have demonstrated feasibility of robotic HAIP placement, comparison of outcomes with open placement is lackin ... Full text Link to item CiteRecent Grants
Evaluation of voltage-gated calcium ion channels as a therapeutic target in intrahepatic cholangiocarcinoma
FellowshipPI-Fellow · Awarded by National Institutes of Health · 2022 - 2024View All Grants